Search

Search Results

• 

  Psoriasis and family history of psoriasis may not affect disease severity of rheumatoid arthritis

  N. Şen, R. Mercan, G. Geçmez, B. Ediz, O. Volkan, S. Yilmaz-Oner, M.E. Tezcan

  07-02-2022

  https://doi.org/10.4081/reumatismo.2021.1453

  5735

  PDF: 705

• The current role of ultrasound in the assessment of crystal-related arthropathies

  M. Gutierrez, E. Filippucci, F. Salaffi, W. Grassi

  216-221

  https://doi.org/10.4081/reumatismo.2009.216

  1309

  PDF: 1583

• Retention rate of abatacept in rheumatoid arthritis patients in a real-life setting: results from a monocentric cohort

  E. Molteni, C. Pirone, F. Ceccarelli, C. Castellani, C. Alessandri, M. Di Franco, V. Riccieri, F.R. Spinelli, R. Priori, R. Scrivo, F. Conti

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1608

  1621

  PDF: 579
• 

  Tophi reduction: ultrasound imaging and correlation with plasma levels of uric acid in patients undergoing treatment for tophaceous gout

  A.J.L. Ferrari, A.R. Corrêa Fernandes, R. de Almeida Agustinelli, H. Seike, E. de Ávila Fernandes

  75-80

  09-07-2019

  https://doi.org/10.4081/reumatismo.2019.1058

  1369

  PDF: 874

• Antinflammatory therapy and cardiovascular risk: a consensus view

  D. Gatti, S. Adami, B. Canesi, M.A. Cimmino, O. Della Casa, M. Del Tacca, C. Klersy, G. Leardini, P. Patrignani, L. Punzi, S. Bombardieri

  85-93

  https://doi.org/10.4081/reumatismo.2006.85

  1652

  PDF: 1145

• Infliximab therapy for Crohn’s disease in the presence of chronic hepatitis C infection - Reply

  M. Galeazzi

  112

  https://doi.org/10.4081/reumatismo.2003.112

  774

  PDF: 614

• Safety of rituximab in rheumatoid arthritis

  M. Covelli, P. Sarzi-Puttini, F. Atzeni, P. Macchioni

  101-106

  https://doi.org/10.4081/reumatismo.2010.101

  1682

  PDF: 1027

• Percutaneous vertebroplasty as therapy of vertebral fractures: results in a series of osteoporotic patients

  C.U. Manzini, L. Bernini, S. Vallone, F. Cavallari, C. Ferri

  209-214

  https://doi.org/10.4081/reumatismo.2007.209

  918

  PDF: 1049

• The safety of interleukin-1 receptor antagonist (anakinra) in the treatment of rheumatoid arthritis

  L. Riente

  74-79

  https://doi.org/10.4081/reumatismo.2004.1s.74

  768

  PDF: 908
• 

  COVID-19 pandemic and biological therapy in rheumatologic disorders: how to deal with?

  Z. Ahmadinejad, R. Assari, N. Ayoobi Yazdi, S.-H. Mazloomi, P. Javanshayani, H. Khalili Afousi, V. Ziaee

  173-177

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1289

  1662

  PDF: 1024

• Therapy of systemic sclerosis

  G. Valentini

  1-8

  https://doi.org/10.4081/reumatismo.2004.1

  1032

  PDF: 2305
• 

  Emergence of acute promyelocytic leukemia in a patient with granulomatosis with polyangiitis during treatment with cyclophosphamide: a rare case report

  F.I. Gorial, N.I. Awadh, N.W. Shaheen, A. Dheyaa, Z.H. Ali, N. Wajdi

  19-12-2023

  https://doi.org/10.4081/reumatismo.2023.1593

  1314

  PDF: 332

• Polyarticular heterotopic ossification complicating drug induced coma

  S. Antonelli, G.D. Sebastiani

  59-61

  https://doi.org/10.4081/reumatismo.2002.59

  658

  PDF: 848
• 

  Patients with anti-small ubiquitin-like modifier activating enzyme-positive dermatomyositis resembling antisynthetase syndrome with poor prognosis: a bicentric international retrospective study and literature review

  Camila Gusmão Vicente de Carvalho, Barbara Bayeh, Fernando Henrique Carlos de Souza, Renata Miossi, Pleiades Tiharu Inaoka, Takashi Matsushita, Naoki Mugii, Samuel Katsuyuki Shinjo

  09-10-2024

  https://doi.org/10.4081/reumatismo.2024.1686

  2258

  PDF: 322

• Rheumatoid factor positivity rather than anti-CCP positivity, a lower disability and a lower number of anti-TNFα agents failed are associated with response to rituximab in rheumatoid arthritis

  L. Quartuccio, S. Salvin, M. Saracco, S. Lombardi, M. Fabris, E. Mansutti, M. Maset, S. Pellerito, S. De Vita

  182-186

  https://doi.org/10.4081/reumatismo.2009.182

  1027

  PDF: 737

• Hyper-IgD syndrome and hereditary periodic fever syndromes

  R. Scolozzi, A. Boccafogli, L. Vicentini

  147-155

  https://doi.org/10.4081/reumatismo.2004.147

  1199

  PDF: 3341

• The heterogeneity of lung involvement in vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic syndrome: a case of hypersensitivity pneumonitis-like pattern

  C. Iannone, M.R. Pellico, C. Campochiaro, L. Tescaro, M. Zompatori, A. Caminati, S. Harari, R. Caporali

  24-06-2024

  https://doi.org/10.4081/reumatismo.2024.1611

  1390

  PDF: 601
• 

  The vicious cycle of physical inactivity, fatigue and kinesiophobia in patients with fibromyalgia syndrome

  B. Cigdem Karacay, T. Sahbaz, C. Medin Ceylan

  21-03-2023

  https://doi.org/10.4081/reumatismo.2022.1502

  1893

  PDF: 1017

• IL-1Ra (recombinant human IL-1 receptor antagonist) in the treatment of rheumatoid arthritis: the efficacy

  U. Fiocco, M. Vezzù, L. Cozzi, S. Todesco

  62-73

  https://doi.org/10.4081/reumatismo.2004.1s.62

  1301

  PDF: 1932
• 

  The role of anifrolumab in reshaping the treatment landscape of extra-renal systemic lupus erythematosus

  Fulvia Ceccarelli, Matteo Piga, Alessandra Bortoluzzi, Laura Coladonato, Micaela Fredi, Daniele Mauro, Chiara Tani, Luca Iaccarino

  23-07-2025

  https://doi.org/10.4081/reumatismo.2025.1830

  676

  PDF: 115
• 

  Psoriatic spondyloarthritis and Sjögren syndrome: a casual association?

  V. Bruzzese, C. Marrese, P. Scolieri, J. Pepe

  170-172

  19-11-2020

  https://doi.org/10.4081/reumatismo.2020.1287

  1169

  PDF: 695

• Fluoroquinolone-induced bilateral rupture of the Achilles tendon: clinical and sonographic findings

  E. Filippucci, A. Farina, F. Bartolucci, C. Spallacci, P. Busilacchi, W. Grassi

  267-269

  https://doi.org/10.4081/reumatismo.2003.267

  1727

  PDF: 5406

• How much does an antiinflammatory treatment cost?

  D. Gatti, O. Viapiana, G. Colombo, S. Adami

  248-252

  https://doi.org/10.4081/reumatismo.2010.248

  1265

  PDF: 682

• The treatment of diffuse cutaneous systemic sclerosis with autologous hemopoietic stem cells transplantation (HSCT): our experience on 2 cases

  I. Miniati, R. Saccardi, F. Pagliai, S. Guiducci, A. Bosi, S. Guidi, S. Urbani, A. Tyndall, M. Matucci Cerinic

  277-282

  https://doi.org/10.4081/reumatismo.2005.277

  992

  PDF: 1518
• 

  Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review

  Ana Martins, Sara Ganhão, Francisca Aguiar, Mariana Rodrigues, Iva Brito

  11-11-2024

  https://doi.org/10.4081/reumatismo.2024.1640

  1543

  PDF: 258
• 

  Subclinical TRAPS treated with canakinumab

  M. Amatruda, N.S. Carucci, C. Fede, G. Conti

  131-134

  03-08-2021

  https://doi.org/10.4081/reumatismo.2021.1406

  2692

  PDF: 614

• The main stages in the history of systemic lupus erythematosus

  M. Rampudda, P. Marson, G. Pasero

  145-152

  https://doi.org/10.4081/reumatismo.2009.145

  1935

  PDF: 1879

• Recommendations for the appropriate use of anti-TNFα therapy in patients with psoriatic arthritis

  C. Salvarani, I. Olivieri, F. Cantini, A. Marchesoni, L. Punzi, R. Scarpa, M. Matucci Cerinic

  133-138

  https://doi.org/10.4081/reumatismo.2004.133

  1394

  PDF: 910

• Kidney involvement in rheumatoid arthritis

  A. Icardi, P. Araghi, M. Ciabattoni, U. Romano, P. Lazzarini, G. Bianchi

  76-85

  https://doi.org/10.4081/reumatismo.2003.76

  5590

  PDF: 7648
• 

  Diagnosis and treatment of interstitial lung disease related to systemic autoimmune myopathies: a narrative review

  F.H.C. De Souza, D.B. De Araújo, L.S. Hoff, B.G. Baldi, M.S.M.S. Faria, L.F da Rocha Junior, L.R.S Da Silva, G.L Behrens Pinto, M.C. Bezerra, R. Miossi, R.A. Cordeiro, S.K Shinjo

  08-05-2023

  https://doi.org/10.4081/reumatismo.2023.1571

  2101

  PDF: 1325

• Gitelman syndrome associated with chondrocalcinosis: description of two cases

  M. Gutierrez, F. Silveri, C. Bertolazzi, G. Giacchetti, M. Tardella, L. Di Geso, E. Filippucci, W. Grassi

  60-64

  https://doi.org/10.4081/reumatismo.2010.60

  1487

  PDF: 1273

• Therapeutic gene transfer for rheumatoid arthritis

  M.C. Boissier, N. Bessis

  51-61

  https://doi.org/10.4081/reumatismo.2004.1s.51

  724

  PDF: 715
• 

  Retention rate and predictor factors of drug discontinuation in axial spondyloarthritis: a focus on certolizumab and secukinumab

  Ebru Atalar, Hatice Ecem Konak, Pınar Akyüz Dağlı, Bahar Özdemir Ulusoy, Özlem Karakaş, Kevser Orhan, Rezan Koçak Ulucaköy, Esra Kayacan Erdoğan, Serdar Can Güven, Orhan Küçükşahin, İsmail Doğan, Hakan Babaoğlu, Yüksel Maraş, Şükran Erten, Ahmet Omma, Berkan Armağan

  26-06-2025

  https://doi.org/10.4081/reumatismo.2025.1792

  1229

  PDF: 174

• A short history of anti-rheumatic therapy. III. Non steroidal anti-inflammatory drugs

  G. Pasero, P. Marson

  225-232

  https://doi.org/10.4081/reumatismo.2010.225

  1656

  PDF: 1204

• Wegener’s granulomatosis: an analysis of 50 patients

  G. Di Comite, G. Bonavida, E. Bozzolo, S. Bozzolo, S. Bianchi, G. Ciboddo, M. Tresoldi, L. Praderio, M.G. Sabbadini

  187-192

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.187

  838

  PDF: 1555

• Assessment of liver and kidney function in patients with ankylosing spondylitis on long-term non-steroidal anti-inflammatory drug therapy

  S. Sülükcü, S. Uslu

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1732

  3340

  PDF: 453
• 

  Brachio-cervical inflammatory myopathy associated with systemic sclerosis. Case series and review of literature

  C.S.R. Araujo, R. Miossi, F.H.C. De Souza, M.D. Costa, A.M.S. da Silva, E.D. Campos, E. Zanoteli, S.K. Shinjo

  122-130

  03-08-2021

  https://doi.org/10.4081/reumatismo.2021.1397

  3562

  PDF: 936

• Churg-Strauss syndrome presenting as polymiositis: report of a case

  P. Lazzarin, E. Presotto, A. Polo

  140-144

  https://doi.org/10.4081/reumatismo.2009.140

  1050

  PDF: 1861

• Prevalence of anti-CCP antibodies in systemic sclerosis

  M. Marrone, A. Chialà, M. Tampoia, F. Iannone, L. Raho, M. Covelli, V. Grattagliano, N. Pansini, G. Lapadula

  20-24

  https://doi.org/10.4081/reumatismo.2007.20

  1149

  PDF: 865
• 

  Poncet’s disease diagnostic criteria decodes conundrum: Poncet’s vs pseudo Poncet’s

  V. Shobha, A.M. Desai

  46-50

  01-04-2019

  https://doi.org/10.4081/reumatismo.2019.1114

  1668

  PDF: 1149

• Tissue engineering applications: cartilage lesions repair by the use of autologous chondrocytes

  B. Grigolo, L. Roseti, M. Fiorini, L. De Franceschi, A. Facchini

  364-371

  https://doi.org/10.4081/reumatismo.2002.364

  1156

  PDF: 1334
• 

  Real-world clinical experience with secukinumab in psoriatic arthritis: an observational study and a literature review

  Eleonora Celletti, Giulio Gualdi, Emanuela Sabatini, Francesco Cipollone, Fabio Lobefaro, Paolo Amerio

  27-01-2025

  https://doi.org/10.4081/reumatismo.2025.1694

  1906

  PDF: 125

• Reconstructing the pyramid as a therapeutic approach to rheumatoid arthritis

  G. Ferraccioli

  46-50

  https://doi.org/10.4081/reumatismo.2004.1s.46

  705

  PDF: 701
• 

  Understanding and perceptions of gout: an interdisciplinary assessment among patients, physicians and pharmacists in Italy

  L. Punzi, G. Medea

  31-43

  10-04-2020

  https://doi.org/10.4081/reumatismo.2020.1227

  1581

  PDF: 968
• 

  A short history of anti-rheumatic therapy - VII. Biological agents

  G. Pasero, P. Marson, B. Gatto

  185-194

  09-11-2011

  https://doi.org/10.4081/reumatismo.2011.185

  1520

  PDF: 1247

• Infections in patients with rheumatoid arthritis receiving anti-cytokine therapy: biological mechanisms and clinical aspects

  C. Botsios, P. Ostuni, P. Sfriso, A. Furlan, U. Fiocco, D. Sgarabotto, S. Todesco

  224-235

  https://doi.org/10.4081/reumatismo.2003.224

  1147

  PDF: 2582
• 

  Oxidative stress may be a contributing factor in fibromyalgia patients’ pain mechanisms

  H. Beyaztas, S. Aktas, E.M. Guler, E. Ata

  18-09-2023

  https://doi.org/10.4081/reumatismo.2023.1550

  1881

  PDF: 726

• Validation of the Italian versions of the Bath Ankylosing Spondylitis Functional Index (BASFI) and the Dougados Functional Index (DFI) in patients with ankylosing spondylitis

  F. Salaffi, A. Stancati, A. Silvestri, M. Carotti, W. Grassi

  161-173

  11-04-2005

  https://doi.org/10.4081/reumatismo.2005.161

  2390

  PDF: 2499

• Acute heart failure due to myocarditis in Takayasu’s arteritis

  M.d.L. Castro de Oliveira Figueirôa, M.C. Moura Costa, P. Rocha Lobo, A.L. Souza Pedreira, M. Barreto Santiago

  24-09-2024

  https://doi.org/10.4081/reumatismo.2024.1681

  950

  PDF: 194

• Buschke Scleredema, case report

  R. Foti, R. Leonardi, G. Fichera, M. Di Gangi, C. Leonetti, P. Gangemi, R. De Pasquale

  310-313

  https://doi.org/10.4081/reumatismo.2006.310

  1045

  PDF: 1582